This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Maglio, D. Articles by Nicolau, D. P. Search for Related Content PubMed PubMed Citation Articles by Maglio, D. Articles by Nicolau, D. P.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, May 2003, p. 1771-1773, Vol. 47, No. 5
0066-4804/03/$08.00+0     DOI: 10.1128/AAC.47.5.1771-1773.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

Pharmacokinetic Profile of Meropenem, Administered at 500 Milligrams Every 8 Hours, in Plasma and Cantharidin-Induced Skin Blister Fluid

Center for Anti-Infective Research and Development,¹ Division of Infectious Diseases,⁴ Office for Research, Hartford Hospital, Hartford, Connecticut 06102,³ AstraZeneca Pharmaceuticals, Wilmington, Delaware 19803²

Received 12 September 2002/ Returned for modification 21 January 2003/ Accepted 10 February 2003

The pharmacokinetic disposition of meropenem, administered at 500 mg every 8 h, in plasma and cantharidin-induced blister fluid is described. Peak meropenem concentrations in blister fluid lagged behind peak meropenem concentrations in plasma, while a lower elimination rate from blister fluid was also noted. The mean penetration of meropenem into blister fluid was 67%. The pharmacokinetic profile of meropenem in blister fluid supports the utility of this dose in the management of skin and soft tissue infections.

This article has been cited by other articles:

• Sun, H. K., Duchin, K., Nightingale, C. H., Shaw, J.-P., Seroogy, J., Nicolau, D. P. (2006). Tissue Penetration of Telavancin after Intravenous Administration in Healthy Subjects. Antimicrob. Agents Chemother. 50: 788-790 [Abstract] [Full Text]  
• Sun, H. K., Ong, C. T., Umer, A., Harper, D., Troy, S., Nightingale, C. H., Nicolau, D. P. (2005). Pharmacokinetic Profile of Tigecycline in Serum and Skin Blister Fluid of Healthy Subjects after Multiple Intravenous Administrations. Antimicrob. Agents Chemother. 49: 1629-1632 [Abstract] [Full Text]